In vivo characterization of the novel ebolavirus Bombali virus suggests a low pathogenic potential for humans

References

• Jacob ST, Crozier I, Fischer WA, 2nd, et al. Ebola virus disease. Nat Rev Dis Primers. 2020 Feb 20;6(1):13, doi:10.1038/s41572-020-0147-3.
   PubMed Web of Science ®Google Scholar
• Bausch DG. West Africa 2013 Ebola: from virus outbreak to humanitarian crisis. Curr Top Microbiol Immunol. 2017;411:63–92. doi:10.1007/82_2017_69.
   PubMed Web of Science ®Google Scholar
• Penas JA, Miranda ME, de Los Reyes VC, et al. Risk assessment of Ebola Reston virus in humans in the Philippines. Western Pac Surveill Response J. 2019 Jul-Sep;10(3):1–8. doi:10.5365/wpsar.2017.3.004.
   PubMedGoogle Scholar
• Goldstein T, Anthony SJ, Gbakima A, et al. The discovery of Bombali virus adds further support for bats as hosts of ebolaviruses. Nat Microbiol. 2018 Oct;3(10):1084–1089. doi:10.1038/s41564-018-0227-2.
   PubMed Web of Science ®Google Scholar
• Forbes KM, Webala PW, Jaaskelainen AJ, et al. Bombali Virus in Mops condylurus Bat, Kenya. Emerg Infect Dis. 2019 May;25(5):955–957. doi:10.3201/eid2505.181666.
   PubMed Web of Science ®Google Scholar
• Karan LS, Makenov MT, Korneev MG, et al. Bombali Virus in Mops condylurus Bats, Guinea. Emerg Infect Dis. 2019 Sep;25(9):1774–1775. doi:10.3201/eid2509.190581.
   PubMed Web of Science ®Google Scholar
• Yamaoka S, Banadyga L, Bray M, et al. Small animal models for studying filovirus pathogenesis. Curr Top Microbiol Immunol. 2017;411:195–227. doi:10.1007/82_2017_9.
   PubMed Web of Science ®Google Scholar
• Escudero-Perez B, Ruibal P, Rottstegge M, et al. Comparative pathogenesis of Ebola virus and Reston virus infection in humanized mice. JCI Insight. 2019 Nov 1;4(21):e126070. doi:10.1172/jci.insight.126070.
   PubMed Web of Science ®Google Scholar
• Hoenen T, Brandt J, Cai Y, et al. Reverse genetics of filoviruses. Curr Top Microbiol Immunol. 2017;411:421–445. doi:10.1007/82_2017_55.
   PubMed Web of Science ®Google Scholar
• Muhlberger E, Weik M, Volchkov VE, et al. Comparison of the transcription and replication strategies of Marburg virus and Ebola virus by using artificial replication systems. J Virol. 1999 Mar;73(3):2333–42.
   PubMed Web of Science ®Google Scholar
• Noda T, Sagara H, Suzuki E, et al. Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. J Virol. 2002 May;76(10):4855–65.
   PubMed Web of Science ®Google Scholar
• Wan W, Clarke M, Norris MJ, et al. Ebola and Marburg virus matrix layers are locally ordered assemblies of VP40 dimers. Elife. 2020 Oct 5;9:e59225; doi: 10.7554/eLife.59225.
   PubMed Web of Science ®Google Scholar
• Moller-Tank S, Maury W. Ebola virus entry: a curious and complex series of events. PLoS Pathog. 2015 Apr;11(4):e1004731, doi:10.1371/journal.ppat.1004731.
   PubMed Web of Science ®Google Scholar
• Watt A, Moukambi F, Banadyga L, et al. A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity. J Virol. 2014 Sep;88(18):10511–24. doi:10.1128/JVI.01272-14.
   PubMed Web of Science ®Google Scholar
• Wendt L, Bostedt L, Hoenen T, et al. High-throughput screening for negative-stranded hemorrhagic fever viruses using reverse genetics. Antiviral Res. 2019 Oct;170:104569, doi:10.1016/j.antiviral.2019.104569.
   PubMed Web of Science ®Google Scholar
• Shabman RS, Hoenen T, Groseth A, et al. An upstream open reading frame modulates ebola virus polymerase translation and virus replication. PLoS Pathog. 2013 Jan;9(1):e1003147, doi:10.1371/journal.ppat.1003147.
   PubMed Web of Science ®Google Scholar
• Groseth A, Marzi A, Hoenen T, et al. The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo. PLoS Pathog. 2012;8(8):e1002847, doi:10.1371/journal.ppat.1002847.
   PubMed Web of Science ®Google Scholar
• Kamper L, Zierke L, Schmidt ML, et al. Assessment of the function and intergenus-compatibility of Ebola and Lloviu virus proteins. J Gen Virol. 2019 May;100(5):760–772. doi:10.1099/jgv.0.001261.
   PubMed Web of Science ®Google Scholar
• Tsuda Y, Hoenen T, Banadyga L, et al. An improved reverse genetics system to overcome cell-type-dependent ebola virus genome plasticity. J Infect Dis. 2015 Oct 1;212(Suppl 2):S129–37. doi:10.1093/infdis/jiu681.
   PubMedGoogle Scholar
• Bodmer BS, Gressler J, Schmidt ML, et al. Differences in viral RNA synthesis but Not budding or entry contribute to the in vitro attenuation of reston virus compared to ebola virus. Microorganisms. 2020 Aug 11;8(8):1215. doi:10.3390/microorganisms8081215.
   PubMed Web of Science ®Google Scholar
• Mastronarde DN, Held SR. Automated tilt series alignment and tomographic reconstruction in IMOD. J Struct Biol. 2017 Feb;197(2):102–113. doi:10.1016/j.jsb.2016.07.011.
   PubMed Web of Science ®Google Scholar
• Meyerholz DK, Beck AP. Fundamental concepts for semiquantitative tissue scoring in translational research. ILAR J. 2018 Dec 1;59(1):13–17. doi:10.1093/ilar/ily025.
   PubMed Web of Science ®Google Scholar
• Bodmer BS, Zierke L, Wendt L, et al. Remdesivir inhibits the polymerases of the novel filoviruses Lloviu and Bombali virus. Antiviral Res. 2021 Aug;192:105120, doi:10.1016/j.antiviral.2021.105120.
   PubMed Web of Science ®Google Scholar
• Timmins J, Scianimanico S, Schoehn G, et al. Vesicular release of ebola virus matrix protein VP40. Virology. 2001 Apr 25;283(1):1–6. doi:10.1006/viro.2001.0860.
   PubMed Web of Science ®Google Scholar
• Jasenosky LD, Neumann G, Lukashevich I, et al. Ebola virus VP40-induced particle formation and association with the lipid bilayer. J Virol. 2001 Jun;75(11):5205–14.
   PubMed Web of Science ®Google Scholar
• Winter SL, Chlanda P. Dual-axis Volta phase plate cryo-electron tomography of Ebola virus-like particles reveals actin-VP40 interactions. J Struct Biol. 2021 Jun;213(2):107742, doi:10.1016/j.jsb.2021.107742.
   PubMedGoogle Scholar
• Lee JE, Saphire EO. Ebolavirus glycoprotein structure and mechanism of entry. Future Virol. 2009;4(6):621–635. doi:10.2217/fvl.09.56.
   PubMed Web of Science ®Google Scholar
• Lanini S, Portella G, Vairo F, et al. Blood kinetics of Ebola virus in survivors and nonsurvivors. J Clin Invest. 2015 Dec;125(12):4692–8. doi:10.1172/JCI83111.
   PubMed Web of Science ®Google Scholar
• Schieffelin JS, Shaffer JG, Goba A, et al. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med. 2014 Nov 27;371(22):2092–100. doi: 10.1056/NEJMoa1411680.
   PubMed Web of Science ®Google Scholar
• de La Vega MA, Caleo G, Audet J, et al. Ebola viral load at diagnosis associates with patient outcome and outbreak evolution. J Clin Invest. 2015 Dec;125(12):4421–8. doi:10.1172/JCI83162.
   PubMed Web of Science ®Google Scholar
• Bird BH, Spengler JR, Chakrabarti AK, et al. Humanized mouse model of ebola virus disease mimics the immune responses in human disease. J Infect Dis. 2016 Mar 1;213(5):703–11. doi:10.1093/infdis/jiv538.
   PubMed Web of Science ®Google Scholar
• He FB, Khan H, Huttunen M, et al. Filovirus VP24 proteins differentially regulate RIG-I and MDA5-dependent type I and III interferon promoter activation. Front Immunol. 2021;12:694105, doi:10.3389/fimmu.2021.694105.
   PubMed Web of Science ®Google Scholar
• Schwarz TM, Edwards MR, Diederichs A, et al. VP24-Karyopherin alpha binding affinities differ between ebolavirus species, influencing interferon inhibition and VP24 stability. J Virol. 2017 Feb 15;91(4):e01715–16, doi:10.1128/JVI.01715-16.
   PubMed Web of Science ®Google Scholar
• Olejnik J, Forero A, Deflube LR, et al. Ebolaviruses associated with differential pathogenicity induce distinct host responses in human macrophages. J Virol. 2017 Jun 1;91(11):694105, doi:10.1128/JVI.00179-17.
   Web of Science ®Google Scholar
• Bosworth A, Dowall SD, Armstrong S, et al. Investigating the cellular transcriptomic response induced by the makona variant of ebola virus in differentiated THP-1 cells. Viruses. 2019 Nov 4;11(11):1023, doi:10.3390/v11111023.
   PubMed Web of Science ®Google Scholar
• Bausch DG, Towner JS, Dowell SF, et al. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis. 2007 Nov 15;196(Suppl 2):S142–7. doi:10.1086/520545.
   PubMed Web of Science ®Google Scholar
• Osterholm MT, Moore KA, Kelley NS, et al. Transmission of Ebola viruses: what we know and what we do not know. mBio. 2015 Feb 19;6(2):e00137, doi:10.1128/mBio.00137-15.
   PubMed Web of Science ®Google Scholar
• Ludtke A, Oestereich L, Ruibal P, et al. Ebola virus disease in mice with transplanted human hematopoietic stem cells. J Virol. 2015 Apr;89(8):4700–4. doi:10.1128/JVI.03546-14.
   PubMed Web of Science ®Google Scholar
• Boehmann Y, Enterlein S, Randolf A, et al. A reconstituted replication and transcription system for Ebola virus Reston and comparison with Ebola virus Zaire. Virology. 2005 Feb 5;332(1):406–17. doi:10.1016/j.virol.2004.11.018.
   PubMed Web of Science ®Google Scholar
• Munoz-Fontela C, McElroy AK. Ebola virus disease in humans: pathophysiology and immunity. Curr Top Microbiol Immunol. 2017;411:141–169. doi:10.1007/82_2017_11.
   PubMed Web of Science ®Google Scholar
• Mohamadzadeh M, Chen L, Schmaljohn AL. How Ebola and Marburg viruses battle the immune system. Nat Rev Immunol. 2007 Jul;7(7):556–67. doi:10.1038/nri2098.
   PubMed Web of Science ®Google Scholar
• Spengler JR, Saturday G, Lavender KJ, et al. Severity of disease in humanized mice infected with ebola virus or reston virus is associated with magnitude of early viral replication in liver. J Infect Dis. 2017 Dec 27;217(1):58–63. doi:10.1093/infdis/jix562.
   PubMed Web of Science ®Google Scholar
• Spiegelberg L, Wahl-Jensen V, Kolesnikova L, et al. Genus-specific recruitment of filovirus ribonucleoprotein complexes into budding particles. J Gen Virol. 2011 Dec;92(Pt 12):2900–2905. doi:10.1099/vir.0.036863-0.
   PubMedGoogle Scholar
• Ilinykh PA, Shen X, Flyak AI, et al. Chimeric filoviruses for identification and characterization of monoclonal antibodies. J Virol. 2016 Apr;90(8):3890–3901. doi:10.1128/JVI.00101-16.
   PubMed Web of Science ®Google Scholar
• Prins KC, Delpeut S, Leung DW, et al. Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in Guinea pigs. J Virol. 2010 Mar;84(6):3004–15. doi:10.1128/JVI.02459-09.
   PubMed Web of Science ®Google Scholar
• Hartman AL, Dover JE, Towner JS, et al. Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication. J Virol. 2006 Jul;80(13):6430–40. doi:10.1128/JVI.00044-06.
   PubMed Web of Science ®Google Scholar